Prevalence of hepatitis G virus (HGV) infection in an endemic area of hepatitis C virus (HCV) infection

Hepatogastroenterology. 2000 Sep-Oct;47(35):1340-2.

Abstract

Background/aims: We investigated the prevalence of hepatitis G virus infection among inhabitants of a hepatitis C virus endemic area.

Methodology: Two hundred and eighty-eight inhabitants, who underwent medical examinations for health screening, were enrolled in this epidemiological study. HGV RNA and HCV RNA were detected by polymerase chain reaction. We also examined anti-HGV envelope protein (E2) antibodies in all serum samples.

Results: In these 288 inhabitants, we found anti-HCV antibodies (HCV-Ab) and HCV RNA in 28.5% and 17.4%, respectively. HGV RNA and anti-HGV E2 were detected in 9 (3.1%) and 16 (5.5%), respectively. One patient was positive for both HGV RNA and anti-HGV E2. The exposure rate, expressed as the percentage of people with HGV RNA and/or anti-HGV E2, was 8.3%, which was significantly lower than the incidence of positive HCV-Ab. Of the 24 patients with HGV RNA and/or anti-HGV E2, 15 (62.5%) were positive for HCV-Ab, of those HCV RNA was detected in 9 (37.5%). Further, we found a higher prevalence of HGV exposure in patients with HCV-Ab than in those without (8.3% vs. 4.4%).

Conclusions: HGV infection was not identical to the epidemic hepatitis C virus infection among inhabitants of this town, suggesting that hepatitis C virus might be less infectious than hepatitis C virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Endemic Diseases*
  • Female
  • Flaviviridae*
  • Hepatitis Antibodies / blood
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood
  • Hepatitis, Viral, Human / epidemiology*
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral / blood

Substances

  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • RNA, Viral